
Most plan sponsors receive a report showing what they spent. What they often don't receive is an answer to the more important question: whether they spent it well.
In this recent episode of The Granite List Live, Michelle Kamprath, Head of Clinical & Analytic Strategy at Expion Health, explores why that question is so difficult to answer.
Drawing on more than 20 years in pharmacy outcomes and PBM strategy, Michelle examines the forces working against visibility, from rebates that arrive months after the claims they relate to, to prescription activity happening entirely outside the benefit, and outlines what plan sponsors can do to regain control of their total prescription economics.
For the teams building pharmacy forward
Get the Expion Health® perspective on the trends, decisions, and market shifts redefining how pharmacy value is created.
Move beyond the pharmacy black box
See how Expion helps organizations build pharmacy strategies with more visibility, flexibility and control from the start.
News & Insights